HLS Therapeutics Inc. announced that Bill Wells, Executive Chair of the Board, has retired from the board and his executive duties at HLS effective May 23, 2022. Mr. Wells intends to focus on other business interests and has agreed to work with the Company to facilitate an orderly transition. Greg Gubitz has been appointed Chair of the Board effective immediately.

Mr. Wells co-founded HLS in 2014 and has served since inception as Executive Chair as well as President and Chair of HLS's Barbados subsidiary. Before that he was involved in three successful turnaround efforts of major public companies and led the turnaround of Biovail, first as Lead Director of the board of directors and then as Chief Executive Officer.